Emil Kakkis

Opinion author

Emil Kakkis, M.D., Ph.D., is a medical geneticist who has been involved in 11 approved rare disease drugs and is currently the CEO of Ultragenyx, a company focused on developing treatments for rare and ultrarare diseases.

Night city road with light motion effect in vector

Opinion

What Accelerated Approval’s Naysayers Miss

By speeding lifesaving drugs’ way to market and focusing on the underlying causes of disease, the pathway has helped save many lives.

December 9, 2024

5 min read

Emil Kakkis